Strengthening Regional Learning for Hemophilia and Sickle Cell Disease Care – Novo Nordisk
Novo Nordisk shared a post on LinkedIn:
“Strengthening regional learning for haemophilia and sickle cell disease care in the Caribbean.
Building on NNHF-supported projects in Jamaica and the Dominican Republic, where partners have worked to strengthen haemophilia care, NNHF is supporting efforts to explore a stronger regional Caribbean coalition.
An NNHF-hosted workshop took place in Santo Domingo, Dominican Republic, bringing together medical experts from Jamaica and the Dominican Republic, as well as representatives from the American Society of Hematology (ASH), to discuss shared challenges and opportunities for integrated care approaches, regional collaboration and data-driven advocacy.
The discussions focused on strengthening government ownership and empowering patient organisations, highlighting opportunities for shared learning, stronger regional connections and more coordinated approaches to care.
As a next step, partners will continue to share experiences and best practices to strengthen the partnership across the Caribbean.
Thank you to NNHF partners, ASH and our NNHF expert volunteers for their time, experience and commitment!”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring